arrow
J

John Choi

Stanford University
H指数:52
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

When Central Tolerance Fails: Thymic Malignancies at the Intersection of Cancer Immunity and Autoimmunity

当中枢耐受失败:胸腺恶性肿瘤——癌症免疫与自身免疫的交汇点

Cancers
IF4.4
2026-02-260
OAAI
Prospective Evaluation of the Pathologic Diagnosis and Treatment Outcomes of Pediatric Burkitt Lymphoma in the Central American Pediatric Hematology-Oncology Association Consortium
2025-03-010
OA
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

儿童 γ δ t-all的生物学和临床分析将LMO2/STAG2重排确定为极高风险

2024-06-242
PRE
The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤 (第36卷,1720页,2022)

LEUKEMIA
IF13.4
2023-07-1915
OAAI
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia (vol 14, 809, 2023)
2023-03-090
OAAI
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
2023-02-139
OAAI
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤

LEUKEMIA
IF13.4
2022-06-221.6K
OAAI
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

世界卫生组织第5版血淋巴肿瘤分类: 骨髓和组织细胞/树突状肿瘤

LEUKEMIA
IF13.4
2022-06-221.8K
OAAI
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy
2022-01-015
OA